Preservation solution in heart transplantation
Acute graft failure still accounts for approximately 20–30% of early deaths after heart transplantation [1, 2]. This complication is clearly multifactorial. Thus, some of these failures can be related to the status of the donor heart (unrecognized existence of parietal and/or coronary abnormalities, hemodynamic instability at the time of harvest). At the opposing end of the sequence of events that the graft must go through, implantation and early reperfusion are critical steps during which damage can be induced by suboptimal preservation techniques. Nevertheless, it is usually admitted that most of this damage occurs during the ex-vivo transportation period. Theoretically, this damage could be avoided by continuous perfusion of the graft with blood or oxygenated crystalloid solution. For practical reasons, however, these perfusion techniques have not gained clinical acceptance and static immersion in hypothermic media remains the cornerstone of organ preservation. Consequently, the following remarks will focus on the principles of formulation and clinical applications of these solutions designed for initial arrest and subsequent storage of donor hearts.
KeywordsHeart Transplantation Calcium Overload Organ Preservation Donor Heart Cardiac Allograft Vasculopathy
Unable to display preview. Download preview PDF.
- 2.De Maria R, Minoli L, Parolini M et al. Prognostic determinants of six-month morbidity and mortality in heart transplant recipients. J. Heart Lung Transplant. 1996; 15: 124–135.Google Scholar
- 12.Sumimoto R, Dohi K, Fukuda Y, Urushihara T, Sumimoto K, Kamada N. A comparison of histidine lactobionate solution with University of Wisconsin solution for rat liver and heart preservation. Transplant. Int. 1992; 5(Suppl 1): S408–410.Google Scholar